SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-025251
Filing Date
2024-02-20
Accepted
2024-02-20 08:42:49
Documents
16
Period of Report
2024-02-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246604d3_8k.htm   iXBRL 8-K 48576
2 EXHIBIT 3.1 tm246604d3_ex3-1.htm EX-3.1 7496
3 EXHIBIT 3.2 tm246604d3_ex3-2.htm EX-3.2 58050
  Complete submission text file 0001104659-24-025251.txt   313267

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA icvx-20240219.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE icvx-20240219_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icvx-20240219_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm246604d3_8k_htm.xml XML 3838
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 24650993
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)